NSTG News 16.67 Nanostring Technologies Inc (NSTG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nanostring Technologies Inc (NSTG) 16.67 $NSTG

NanoString Technologies to Release First Quarter 2014 Financial Results and Host Conference Call on Wednesday, May 7, 2014
GlobeNewswire - Wed Apr 16, 3:16PM CDT
NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release 2014 first quarter financial results after the close of trading on Wednesday, May 7, 2014. Company management will host an investment community conference call beginning at 4:30pm ET to discuss those results and to provide a business update.

Nasdaq stocks posting largest percentage decreases
AP - Mon Apr 07, 12:50PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

NanoString Technologies Introduces Novel PanCancer Gene Expression Panel for Multiplexed Pathway Analysis
Business Wire - Mon Apr 07, 6:30AM CDT
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of the nCounter(R) PanCancer Pathways Panel, a highly-multiplexed, digital gene expression assay that offers a unique way for translational researchers to investigate cancer biology across all major cancer pathways. The company made the announcement at the 105th Annual Meeting of the American Association for Cancer Research (AACR) in San Diego.

NanoString Technologies enters into USD45m six year term loan agreement with Capital Royalty
M2 - Fri Apr 04, 5:31AM CDT
Life science company NanoString Technologies (NasdaqGM:NSTG) disclosed on Thursday the launch of up to USD45m term loan agreement with Capital Royalty and certain of its affiliates.

NanoString Technologies Announces $45 Million Term Loan Agreement With Capital Royalty
GlobeNewswire - Thu Apr 03, 3:03PM CDT
NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a term loan agreement with Capital Royalty L.P. and certain of its affiliates. The agreement provides NanoString with up to $45 million of available borrowing capacity.

Single Cell Omics Trends - Global Market Overivew 2014
M2 - Tue Apr 01, 10:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j5vvw9/single_cell_omics) has announced the addition of the "Single Cell Omics Trends" report to their offering. Single Cell Omics, a cutting edge technology, mainly integrates advanced technology with biology for a variety of single cell applications. The technology helps to study single cells at a much deeper level which allows identifying important genomic variations. The report analyzes and presents an overview of Single Cell Omics market worldwide. The report also offers global market estimates and projections for Single Cell Omics technology and products in US dollars for years 2012 through 2017. Key geographic market quantitatively analysed include the Unites States, Europe, Asia Pacific, and Japan. Supported with 6 market data tables, the report provides a review of market trends, application areas, growth opportunities, and challenges. The data table highlights global Single Cell Omics market by applications, technology, product, region, and field of study. Key Topics Covered: 1. SINGLE CELL OMICS - A MARKET OVERVIEW - Single Cell Analysis - A Revolutionary Technology Changing Market Dynamics - Single Cell Genomics - An Introduction - Biological Research Shifting from Tissue/Organ Level Approach to a Single Cell - Single Cell Analysis - Role of Omics - Single-Cell Isolation Techniques - Single Cell Omics - Applications - Single Cell Omics - Major Application Areas - SCA Devices - Technological Improvements - Single Cell Omics - Growth Opportunities Vs. Challenges - Global Single Cell Omics Market to Register Mammoth Growth Rate - Single Cell Omics Market by Technology - Single Cell Omics Market by Field of Study - Single Cell Omics Market by Applications - Picodroplet Single Cell Analysis Technology Witnesses Significant Surge - Major Players in the Single Cell Isolation Market - Major Players in the Single Cell Sample Preparation Market - Major Players in the Single Cell Genomic Analysis Market 2. RECENT INDUSTRY ACTIVITY - Genome Institute of Singapore and Fluidigm Open GIS-Fluidigm - Single-Cell Omics Center in Singapore - Sphere Fluidics Develops New Technologies for Single Cell Analysis 3. MARKET PARTICIPANTS - BD Biosciences - BioNano Genomics, Inc. - DVS Sciences, Inc. - Fluidigm Corporation - Fluxion Biosciences, Inc. - Life Technologies Corporation - Molecular Machines & Industries (MMI) - NanoString Technologies, Inc. - NuGEN Technologies, Inc. - Qiagen NV - Roche Applied Science - Silicon Biosystems - Sphere Fluidics Ltd. - Tataa Biocenter AB - Thermo Fisher, HCA Company 4. APPENDIX For more information visit http://www.researchandmarkets.com/research/j5...cell_omics

Newly Published Analytical Validation Study Shows Precision and Reproducibility of PAM50-Based Prosigna Breast Cancer Assay in Multiple Clinical Testing Laboratories
Business Wire - Thu Mar 13, 3:30PM CDT
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that a study published online in the journal BMC Cancer demonstrates the analytical validity of the PAM50-based Prosigna(TM) Breast Cancer Prognostic Gene Signature Assay. Based on highly concordant results across multiple clinical laboratory sites, technicians, and manufacturing lots of Prosigna reagents, the authors concluded that the study provides a strong body of evidence supporting the decentralized use of the Prosigna Assay on the nCounter Dx Analysis System as a prognostic tool for the risk of recurrence (ROR) in selected breast cancer patients.

NanoString Technologies Releases Fourth Quarter and Full Year 2013 Financial Results and Provides 2014 Outlook
GlobeNewswire - Wed Feb 26, 3:09PM CST
- Strong Q4 2013 Revenue Growth of 56% Year over Year -

NanoString Technologies to Participate in the Cowen 34th Annual Health Care Conference
GlobeNewswire - Wed Feb 19, 3:05PM CST
NanoString Technologies, Inc. (Nasdaq:NSTG), today announced that its management is scheduled to participate in the Cowen 34 Annual Health Care Conference in Boston.

Study Confirms Ability of the Prosigna Assay to Assess Risk of Late Distant Recurrence in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer
Business Wire - Wed Feb 12, 6:30AM CST
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that a study published online in Clinical Cancer Research showed that the PAM50 assay, on which the company's Prosigna(TM) Breast Cancer Prognostic Gene Signature Assay is based, accurately assessed the risk of late distant recurrence in postmenopausal women with estrogen receptor-positive (ER+) early-stage breast cancer. The study, titled, "The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer" was conducted by researchers from the Austrian Breast & Colorectal Cancer Study Group and can be found online at: http://clincancerres.aacrjournals.org/content...5.abstract.

NanoString Technologies Launches Commercial Reagents to Enable Laboratories to Rapidly Develop Tests From Translational Research Discoveries
Business Wire - Tue Feb 11, 6:30AM CST
NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the global commercial launch of the nCounter Elements(TM) General Purpose Reagents (GPRs), a solution that enables clinical laboratories to independently develop multiplexed genomic assays and then rapidly translate those assays into clinical diagnostics as Laboratory Developed Tests (LDTs). The announcement, made at the 21st International Molecular Medicine Tri-Conference (TRI-CON) taking place in San Francisco, February 9 - 14, marks the conclusion of a successful early access program that involved 22 participants from five countries in North America, Europe, and Asia.

NanoString Technologies to Release Fourth Quarter 2013 Financial Results and Host Conference Call on Wednesday, February 26, 2014
GlobeNewswire - Wed Feb 05, 3:05PM CST
NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release 2013 fourth quarter financial results after the close of trading on Wednesday, February 26, 2014. Company management will host an investment community conference call beginning at 4:30pm ET to discuss those results and to provide a business update.

NanoString Technologies to Participate in the Leerink Swann Global Healthcare Conference 2014
GlobeNewswire - Wed Jan 29, 3:02PM CST
NanoString Technologies, Inc. (Nasdaq:NSTG), today announced that its management is scheduled to participate in the Leerink Swann Global Healthcare Conference 2014 in New York.

NanoString Technologies Inc prices USD55m in follow-on offering
M2 - Fri Jan 24, 4:18AM CST
Molecular diagnostic company NanoString Technologies Inc reported on Thursday that it has priced a follow-on public offering of USD55m of its common stock.

NanoString Technologies Prices Follow-On Offering
GlobeNewswire - Thu Jan 23, 5:30PM CST
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of its follow-on public offering of $55 million of its common stock at a price to the public of $18.50 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional $8.25 million of its common stock.

NanoString Technologies Inc announces USD55m in follow-on public offering
M2 - Wed Jan 22, 3:57AM CST
Molecular diagnostic company NanoString Technologies Inc (NasdaqGM:NSTG) reported on Tuesday USD55m proposed follow-on public offering of its common stock.

NanoString Technologies Launches Follow-On Offering
GlobeNewswire - Tue Jan 21, 3:01PM CST
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a proposed follow-on public offering of $55 million of its common stock. In addition, the Company expects to grant the underwriters a 30-day option to purchase up to an additional $8.25 million of its common stock.

LabCorp Launches Breast Cancer Assay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 15, 4:37PM CST
Laboratory Corp. announced the commercial launch of Prosigna Breast Cancer Prognostic Gene Signature Assay.

NanoString Technologies Secures Exclusive Option From Massachusetts General Hospital to License Intellectual Property for New Multiplexed Protein Analysis Method
GlobeNewswire - Wed Jan 15, 3:05PM CST
NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has secured an exclusive option from Massachusetts General Hospital to license intellectual property related to a novel approach for multiplexed protein analysis using the company's nCounter Analysis System. The method was recently published in Science Translational Medicine.

NanoString Technologies Inc files registration statement for USD55m in follow-on public offering
M2 - Tue Jan 14, 5:58AM CST
Life science company NanoString Technologies Inc (NasdaqGM) said on Monday that it has filed a registration statement for a planned follow-on offering of USD55m of its common stock to the public.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Century's Florence Model Openings Put Arizona in Focus

Updated Category News Views 18

Six furnished houses in Florence may sound like a modest ribbon-cutting, but homebuilding is a business of small field signals before the quarterly numbers ever show up. Century Communities is scheduled to host a November grand opening for six model homes spanning two new communities in Florence, Arizona. For investors tracking NYSE:CCS, that is not a thesis by itself. It...

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 15

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading
Four Pending Deals Put Shareholder Terms Under Scrutiny

Updated Category News Views 88

Four corporate transactions landed under a legal microscope on November 18, and that is never background noise for shareholders trying to judge whether the paperwork matches the price. Halper Sadeh LLC says it is investigating proposed deals involving WaFd, Personalis, Dana and Baldwin Group for possible federal securities-law violations and/or fiduciary-duty breaches....

Continue Reading
The Estate Bets Over $1 Billion on Luxury Longevity

Updated Category News Views 0

A billion-dollar wellness promise just wandered into the condominium market. The Estate by sbe says its first three branded residential developments carry combined real estate value above $1 billion and encompass more than 500 units. That is not pocket change, and it is certainly not a routine hotel-brand licensing exercise dressed up with scented candles and a cold...

Continue Reading
Hitachi's Quiet Fusion Bet Is Really About Data Control

Updated Category News Views 16

Weeks of engineering work can vanish because one storage system hiccups, which is a rotten way to learn that data infrastructure belongs in the mission-critical column. Esteyco’s new environment, built with Hitachi Vantara and implemented by Quadrics Sistemas, is not a fusion breakthrough. It is the less glamorous machinery that keeps serious fusion research from...

Continue Reading
GE Aerospace Backs Service Members With $100K Gift

Updated Category News Views 0

A six-figure commitment can look tiny beside jet-engine budgets, yet it can matter a great deal when it reaches people navigating the awkward jump from military service into civilian life. GE Aerospace has committed $100,000 to Embry-Riddle Aeronautical University to support transitioning service members. That is the whole heart of this announcement, and frankly, it is...

Continue Reading
Xailient Tops NIST for Real-World AI Face Recognition

Updated Category News Views 87

In a world where bigger ain't always better, Xailient's latest triumph at NIST's face recognition test has set them apart. On November 17, 2026, the U.S. National Institute of Standards and Technology (NIST) crowned Xailient as the leader in face recognition accuracy for on-device AI, leaving 105 others in the dust. This ain't your run-of-the-mill achievement—it shows...

Continue Reading
Ivanti's AI Push Rests on Data, Control and Results

Updated Category News Views 107

Enterprise AI has a nasty habit of sounding brilliant right up until it meets a messy fleet of laptops, phones, patches and permissions. Ivanti’s latest product push is aimed squarely at that unglamorous collision point: giving AI systems governed access to the operational data inside Ivanti Neurons, then keeping humans and pre-set permissions in charge of what happens...

Continue Reading
Rokt's 164% Growth Shows Checkout Ads Have Real Muscle

Updated Category News Views 0

Checkout screens have become valuable real estate, and Rokt is planting a flag right in the middle of them. The New York ecommerce technology company landed on Deloitte's 2026 Technology Fast 500 after posting 164% revenue growth from 2022 through 2025. That is a meaningful number, not decorative corporate confetti, especially in a digital-ad market where plenty of...

Continue Reading
Villa Group’s Punta Mita Bet Adds 305 Luxury Resort Keys

Updated Category News Views 102

A 12.6-acre slice of Riviera Nayarit coastline is about to get a very expensive makeover, assuming The Villa Group can turn a handsome plan into a functioning resort without the usual development headaches. The company says it has acquired a beachfront parcel in Litibú and intends to build Villa La Valencia Punta Mita, a 305-accommodation luxury property aimed squarely...

Continue Reading

Top 5 Most Recently Viewed Articles

Apple Inc. Faces Class Action Lawsuit Over Securities Fraud

Updated Category News Views 299

Overview of the Class Action Lawsuit Against Apple Inc. The renowned law firm of Kessler Topaz Meltzer & Check, LLP has announced a significant class action lawsuit filed against Apple Inc. The lawsuit, now underway in the United States District Court for the Northern District of California, is focused on claims of securities fraud that impact investors of Apple...

Continue Reading
Oslo Stock Market Experiences Decline Amidst Mixed Performances

Updated Category News Views 102

Oslo Stock Market Experiences Decline The recent trading session on the Oslo Stock Exchange closed with a notable decline, reflecting a complex mixture of performances across various sectors. Generally, the market is affected by fluctuations in key industries such as Media, Transport, and Diversified Financials. Sector Performance Analysis The Oslo OBX index, a critical...

Continue Reading
Doodle's Tender Offer Results: Lexibook Holds Strong Position

Updated Category News Views 210

Doodle's Tender Offer Results Overview In a strategic move within the shares market, the results from Doodle's recent tender offer on Lexibook have been announced. This development is particularly interesting for investors and stakeholders in the electronic leisure products sector. The outcome signifies a notable consolidation of shares following the initiation of...

Continue Reading
Riot Platforms Sees Bullish Signals as Options Trade Surge

Updated Category News Views 283

Riot Platforms Sees Bullish Signals in Options Trading Recent market activities suggest that investors with significant capital are betting on a positive future for Riot Platforms (NASDAQ: RIOT). This turn towards bullish behavior in the stock market highlights the enthusiasm among wealthier traders and institutional investors. The fascinating aspect of this situation is...

Continue Reading
Highlights from Coloplast A/S Annual Meeting and Future Outlook

Updated Category News Views 215

Coloplast A/S Annual General Meeting Insights Coloplast A/S recently hosted its Annual General Meeting, where significant resolutions were discussed and approved. As the company continues to innovate in healthcare, these decisions reflect their commitment to improving the lives of millions. Annual Report Approval One of the main highlights at the meeting was the approval...

Continue Reading